District court decision invalidating claims as inherently anticipated upheld by Federal Circuit

Procedural History – United Therapeutics Corporation v. Liquidia Technologies, Inc. is an appeal and cross appeal from a District of Delaware decision that found (1) claims 1, 4, and 6–8 of U.S. Patent 10,716,793 (“the ’793 patent”) not invalid and infringed, (2) claims 1–3 of U.S. Patent 9,593,066 (“the ’066 patent”) invalid as anticipated, but otherwise infringed, (3) claims 6 and 9 of the ’066 patent invalid as anticipated and (4) claims 6, 8, and 9 of the ’066 patent as not infringed….
By: Allen & Overy LLP
Previous Story

The Role of Insurance Companies in Truck Accident Cases in Florida

Next Story

SEC Adopts New Cybersecurity Reporting Rules, Setting Up Various Compliance Challenges